Partnership supports launch of new biosolvent

Biotechnology company, Circa Group, has announced a partnership with formulation science consultancy, iFormulate, that will support the launch of a new biosolvent, Cyrene.

The chiral dipolar aprotic solvent, Cyrene, offers a bio-based alternative to polar aprotic solvents that are toxic and as such experiencing regulatory pressures.

“The market understands there is no direct drop-in replacement for traditional, toxic solvents — therefore process and formulation trials are crucial for developing bio-based alternatives,” commented Dr Jeff Eaves, general manager at Circa subsidiary company Circa Sustainable Chemicals UK. “As Cyrene is introduced across the market, we are grateful for iFormulate’s considerable industry experience and strong reputation as expert consultants to formulators across the UK and Europe. We look forward to using their formulation knowledge to support our customers.”

Dr David Calvert, director and co-founder of iFormulate, added: “Sustainability is a critical driver for many new formulation programmes. We have followed the development of Cyrene over a number of years and are looking forward to helping the Circa team as they work with customers across a number of the formulation sectors.”